| Novolin N |
019959 |
001 |
351(a) |
insulin isophane human |
Injectable Suspension |
Subcutaneous |
1,000UNITS/10ML (100UNITS/ML) |
Multi-Dose Vial |
1991/07/01
|
Novo Nordisk Inc. |
OTC |
Licensed |
N/A |
N/A |
| Novolin N |
019959 |
002 |
351(a) |
insulin isophane human |
Injectable Suspension |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
1991/07/01
|
Novo Nordisk Inc. |
OTC |
Licensed |
N/A |
N/A |
| Survanta |
020032 |
001 |
351(a) |
beractant |
Suspension |
Intratracheal |
100MG/4ML (25MG/ML) |
Single-Dose Vial |
1991/07/01
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Survanta |
020032 |
002 |
351(a) |
beractant |
Suspension |
Intratracheal |
200MG/8ML (25MG/ML) |
Single-Dose Vial |
1991/07/01
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Novolin R |
019938 |
001 |
351(a) |
insulin human |
Injection |
Subcutaneous |
1,000UNITS/10ML (100UNITS/ML) |
Multi-Dose Vial |
1991/06/25
|
Novo Nordisk Inc. |
OTC |
Licensed |
N/A |
N/A |
| Novolin 70/30 |
019991 |
001 |
351(a) |
insulin isophane human and insulin human |
Injection |
Subcutaneous |
300UNITS/10ML (30UNITS/ML); 700UNITS/10ML (70UNITS/ML) |
Multi-Dose Vial |
1991/06/25
|
Novo Nordisk Inc. |
OTC |
Licensed |
N/A |
N/A |
| Leukine |
103362 |
001 |
351(a) |
sargramostim |
For Injection |
Intravenous, Subcutaneous |
250MCG |
Single-Dose Vial |
1991/03/05
|
Partner Therapeutics, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Leukine |
103362 |
002 |
351(a) |
sargramostim |
Injection |
Intravenous, Subcutaneous |
500MCG/ML |
Multi-Dose Vial |
1991/03/05
|
Partner Therapeutics, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Neupogen |
103353 |
001 |
351(a) |
filgrastim |
Injection |
Intravenous, Subcutaneous |
300MCG/ML |
Single-Dose Vial |
1991/02/20
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Neupogen |
103353 |
002 |
351(a) |
filgrastim |
Injection |
Intravenous, Subcutaneous |
480MCG/1.6ML |
Single-Dose Vial |
1991/02/20
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Alphanine, Alphanine Hp, Alphanine Sd |
103249 |
001 |
351(a) |
Coagulation Factor IX (Human) |
Injection |
Intravenous |
500IU |
Single-Dose Vial |
1990/12/31
|
Grifols Biologicals LLC |
Rx |
Licensed |
|
N/A |
| Alphanine, Alphanine Hp, Alphanine Sd |
103249 |
002 |
351(a) |
Coagulation Factor IX (Human) |
Injection |
Intravenous |
1000IU |
Single-Dose Vial |
1990/12/31
|
Grifols Biologicals LLC |
Rx |
Licensed |
|
N/A |
| Alphanine, Alphanine Hp, Alphanine Sd |
103249 |
003 |
351(a) |
Coagulation Factor IX (Human) |
Injection |
Intravenous |
250IU |
Single-Dose Vial |
1990/12/31
|
Grifols Biologicals LLC |
Disc |
Licensed |
|
N/A |
| Alphanine, Alphanine Hp, Alphanine Sd |
103249 |
004 |
351(a) |
Coagulation Factor IX (Human) |
Injection |
Intravenous |
1500IU |
Single-Dose Vial |
1990/12/31
|
Grifols Biologicals LLC |
Rx |
Licensed |
|
N/A |
| Cytogam |
103189 |
001 |
351(a) |
Cytomegalovirus Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
2.5G/50ML |
Single-Dose Vial |
1990/04/17
|
Kamada Ltd. |
Rx |
Licensed |
|
N/A |
| Adagen |
019818 |
001 |
351(a) |
pegademase bovine |
Injection |
Intramuscular |
375UNITS/1.5ML (250UNITS/ML) |
Single-Dose Vial |
1990/03/21
|
Leadiant Biosciences, Inc |
Disc |
Licensed |
N/A |
N/A |
| Novarel |
017016 |
011 |
351(a) |
chorionic gonadotropin |
For Injection |
Intramuscular |
2,000UNITS |
Multi-Dose Vial |
1990/02/16
|
Ferring Pharmaceuticals Inc. |
Disc |
Licensed |
N/A |
N/A |
| Pedvaxhib |
103237 |
001 |
351(a) |
Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) |
Injection |
Intramuscular |
7.5UG/.5ML |
Single-Dose Vial |
1989/12/20
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
|
N/A |
| Vivotif |
103123 |
001 |
351(a) |
Typhoid Vaccine Live Oral Ty21a |
Capsule |
Oral |
2-6.8 BIL. CFU |
Blister Pack |
1989/12/15
|
Bavarian Nordic A/S |
Rx |
Licensed |
|
N/A |
| Alferon N Injection |
103158 |
001 |
351(a) |
interferon alfa-n3 (human leukocyte derived) |
Injection |
Intravenous |
5MILLION IU/1ML |
Vial |
1989/10/10
|
AIM ImmunoTech Inc. |
Disc |
Licensed |
N/A |
N/A |